Quince Therapeutics

Quince Therapeutics, formely known as Cortexyme, focuses on precision therapeutics targeting debilitating and rare diseases.

helicopter rescue mission save aircraft

Biotech

Cash-strapped Quince finds salvation in reverse merger

Quince began seeking strategic alternatives after its lead candidate failed in a phase 3 trial for a rare pediatric neurodegenerative disease.

Darren Incorvaia May 18, 2026 10:32am

poison pill toxic poison

Quince adopts 'poison pill' to fend off buyout, stock purchases

Apr 6, 2023 8:24am

layoffs boardroom restructuring layoff

Quince to lay off nearly half of team, sell more assets

Jan 30, 2023 6:01pm

Lighthouse

Quince's former leaders return for unwanted Alzheimer's assets

Jan 27, 2023 10:45am

quince jam fruit leaves

Quince hoping to sweeten its fruit with new strategic plan

Aug 1, 2022 10:48am